^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Concentration and volume not specified.

^d Tested in sodium chloride 0.45%.

^e Injected via Y-site into an administration set running azithromycin.

^f Tested in both sodium chloride 0.9% and 0.45%.

^g Lyophilized formulation tested.

^h Quinupristin and dalfopristin components combined.

ⁱ Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^j Run at 100 mL/hr.

^k Tested in Ringer’s injection, lactated.

^l Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

^m Test performed using the lactate salt formulation.

ⁿ Tested in both dextrose 5% and sodium chloride 0.9%.

^o Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^p Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^q Run at 25 mL/hr with dextrose 5% run at 83 mL/hr.

^r Tested as the premixed infusion solution.

^s Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.